Statements (24)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:company
|
gptkbp:CEO |
gptkb:Robert_I._Blum
|
gptkbp:collaboratesWith |
gptkb:Amgen
gptkb:Astellas_Pharma |
gptkbp:country |
gptkb:United_States
|
gptkbp:focus |
cardiovascular diseases
muscle biology neuromuscular diseases |
gptkbp:foundedYear |
1997
|
gptkbp:fullName |
gptkb:Cytokinetics,_Incorporated
|
gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
CYTK
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
gptkb:aficamten
gptkb:omecamtiv_mecarbil reldesemtiv |
gptkbp:numberOfEmployees |
~200 (2023)
|
gptkbp:publiclyTraded |
true
|
gptkbp:researchArea |
small molecule therapeutics
|
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:CYTK
|
gptkbp:website |
https://www.cytokinetics.com/
|
gptkbp:bfsParent |
gptkb:Cytokinetics
|
gptkbp:bfsLayer |
6
|